Navigation Links
Hill-Rom Reports Fourth Quarter Revenue Growth of 14.1 Percent to $424 Million and Adjusted Earnings Per Fully Diluted Share From Continuing Operations of $0.58, an Increase of 52.6 Percent From the Prior Year
Date:11/10/2008

ets

Cash and cash equivalents $221.7 $131.2

Trade accounts receivable, net of

allowances 395.1 356.2

Inventories 100.0 113.7

Other current assets 55.5 53.4

Total current assets 772.3 654.5

Equipment leased to others, net 171.4 190.2

Property, net 125.4 125.6

Other assets 620.8 629.2

Total Assets $1,689.9 $1,599.5

Liabilities

Current Liabilities

Trade accounts payable $99.4 $89.8

Short-term borrowings 122.6 33.7

Other current liabilities 172.7 169.2

Total current liabilities 394.7 292.7

Long-term debt 100.2 100.6

Other long-term liabilities 112.4 128.6

Total Liabilities 607.3 521.9

Shareholders' Equity 1,082.6 1,077.6

Total Liabilities and Shareholders'

Equity $1,689.9 $1,599.5

Financial Guidance for Fiscal Year 2009

Adjusted 2009 Range

2008 Low High

($ in millions, except EPS)

Net Revenues

Capital sales $1,044 $1,159 $1,194

Rental revenues 464 474 489

Total revenues 1,508 1,633 1,683

YoY % Change
'/>"/>

SOURCE Hill-Rom Holdings, Inc.
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19

Related biology technology :

1. Hill-Rom Introduces New Wound Therapy Surface With Innovative Safety and Treatment Features
2. Trubion Pharmaceuticals Inc. Reports Third Quarter and Nine Months 2008 Results
3. Medivation Reports Third Quarter 2008 Financial Results and Provides Corporate Update
4. BMP Sunstone Reports Third Quarter 2008 Financial Results
5. Endocare Reports Financial Results for Third Quarter 2008
6. Caliper Life Sciences Reports Third Quarter 2008 Results; Sharpens Growth Focus, Strengthens Balance Sheet and Reduces Costs
7. Isis Reports Financial Results and Highlights for Third Quarter of 2008
8. OncoGenex Reports Third Quarter Financial Results
9. American Oriental Bioengineering Reports Third Quarter 2008 Financial Results
10. AutoImmune Inc. Reports 2008 Third Quarter Financial Results
11. Dendreon Reports Third Quarter 2008 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Biology News(10 mins):A window that washes itself? 2Stopping MRSA before it becomes dangerous is possible, Sandia/UNM researchers find 2Stopping MRSA before it becomes dangerous is possible, Sandia/UNM researchers find 3DUSA Pharmaceuticals Named to Deloittes 2009 Technology Fast 500 List of Fastest Growing Companies in North America 59892 1DUSA Pharmaceuticals Named to Deloittes 2009 Technology Fast 500 List of Fastest Growing Companies in North America 59892 2DUSA Pharmaceuticals Named to Deloittes 2009 Technology Fast 500 List of Fastest Growing Companies in North America 59892 3Lake Health Celebrates Grand Opening of TriPoint Medical Center 59890 1Lake Health Celebrates Grand Opening of TriPoint Medical Center 59890 2Lake Health Celebrates Grand Opening of TriPoint Medical Center 59890 3Lake Health Celebrates Grand Opening of TriPoint Medical Center 59890 4Lake Health Celebrates Grand Opening of TriPoint Medical Center 59890 5Lake Health Celebrates Grand Opening of TriPoint Medical Center 59890 6Lake Health Celebrates Grand Opening of TriPoint Medical Center 59890 7BioWa and NKTT Announce Licensing of BioWas POTELLIGENT 28R 29 Technology For Use in Antibody Research and Development 14560 1BioWa and NKTT Announce Licensing of BioWas POTELLIGENT 28R 29 Technology For Use in Antibody Research and Development 14560 2BioWa and NKTT Announce Licensing of BioWas POTELLIGENT 28R 29 Technology For Use in Antibody Research and Development 14560 3